Number of Health-Related Data Breaches Increasing
Health plans had most records breached from 2010 to 2017, but providers breached most often
Negligible Drop in Neoplastic Lesion Dx After First Round of FIT
Negligible reduction in neoplastic lesion detection in proximal versus distal colon after first round of FIT
Second Opinion at NCI Center Valuable for Breast CA Patients
Almost 43 percent of those presenting to NCI center for second opinion have change in diagnosis
For Employer-Based Plans, Spending Across Services Steady
Spending increased, but not uniformly, across all categories of health services from 2007 to 2016
More Non-Elderly Americans Uninsured in 2017 Versus 2016
More than 700,000 Americans uninsured in 2017 versus 2016, despite broad economic improvement
Risk of Relapse Up for Teens, Young Adults With Leukemia
Increased risk of on-therapy relapse, relapse after completing therapy versus children with ALL
FDA Approves New Treatment for Squamous Cell Carcinoma
Libtayo is the sixth FDA-approved immune checkpoint inhibitor targeting the PD-1 pathway
September 2018 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for September 2018. This roundup includes...
Risk of Venous Thromboembolism Recurrence High
At 6 months, rates for provoked, unprovoked, cancer-related VTE are 6.8, 6.92, 9.06 per 100 person-years
Handheld Device Inspired by Star Trek May Allow Rapid Diagnosis
Device uses enzyme-based assays to measure metabolites associated with multiple diseases
